Talking Rheumatology Research
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
Talking Rheumatology Research
Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica
•
British Society for Rheumatology
•
Episode 50
How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?
In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.
Further reading:
- Read Steven's full study in Rheumatology
Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.